For the fourth year, these awards recognize outstanding contributions of female leaders and emerging talent in the field of inflammatory bowel disease (IBD) research. TORONTO, OC and KIRKLAND, QC —… Read More
TORONTO, ON — Takeda Canada Inc. (“Takeda”) is pleased to announce that Canadian Blood Services (CBS) has included HyQvia® (Normal Immunoglobulin [Human]) 10% & Recombinant Human Hyaluronidase solution for subcutaneous… Read More
BOTHELL, Wash. — Seagen Inc. (NASDAQ: SGEN) announced the first presentation of data evaluating ADCETRIS® (brentuximab vedotin) in combination with an anti-PD-1 checkpoint inhibitor in non-small cell lung cancer (NSCLC) and… Read More
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, announced that… Read More
VANCOUVER, BC — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, announced that management will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference:… Read More
